Australia markets closed

Biotron Limited (BIT.AX)

ASX - ASX Delayed price. Currency in AUD
Add to watchlist
0.0610-0.0070 (-10.29%)
At close: 04:10PM AEST
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
30/06/2023
30/06/2022
30/06/2021
30/06/2020
Total revenue
50
-
-
-
-
Gross profit
50
-
-
-
-
Operating expenses
Research development
3,232
3,232
2,821
3,137
2,857
Selling general and administrative
1,626
1,626
1,116
1,132
1,124
Total operating expenses
5,039
5,039
4,338
4,666
4,443
Operating income or loss
-5,039
-5,039
-4,338
-4,666
-4,443
Interest expense
4.389
4.389
5.049
1.261
5.118
Total other income/expenses net
803.026
1,431
1,559
1,462
803.026
Income before tax
-3,493
-3,493
-2,781
-3,194
-3,576
Income tax expense
0
0
0
0
0
Income from continuing operations
-3,493
-3,493
-2,781
-3,194
-3,576
Net income
-3,493
-3,493
-2,781
-3,194
-3,576
Net income available to common shareholders
-3,493
-3,493
-2,781
-3,194
-3,576
Basic EPS
-0.00
-0.00
-0.00
-0.00
-0.01
Diluted EPS
-0.00
-0.00
-0.00
-0.00
-0.01
Basic average shares
820,842
820,842
724,786
724,786
675,462
Diluted average shares
820,842
820,842
724,786
724,786
675,462